Schedule 13D ownership disclosure
CARISMA THERAPEUTICS INC
Security class unavailable · CUSIP: 14216R101
Event date: 2023-03-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001068238-23-000067
- Form type
- SC 13D
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Mar 22, 2023
- Reporting period
- Mar 22, 2023
- Description
- Schedule 13D beneficial ownership